(Q44347227)

English

Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions

scientific article published in August 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

author name string

A Ragnauth

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

H Ruegg

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

R J Bodnar

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

767

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8-16

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Ingestive behavior following central [D-Ala2, Leu5, Cys6]-Enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Ventral tegmental area opioid mechanisms and modulation of ingestive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Intra-VTA injections of the mu-opioid antagonist CTOP enhance locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Mediation of insulin hyperphagia by specific central opiate receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 1. 2-Deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Suppression of deprivation-induced food and water intake in rats and mice by naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

The suppressant effects of naloxone on food and water intake in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Opioid receptors in midbrain dopaminergic regions of the rat. I. Mu receptor autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Opioid-induced feeding: localization of sensitive brain sites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Morphine-induced activation of A10 dopamine neurons in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Microinjection of opioid antagonists into the substantia nigra reduces stress-induced eating in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Hyperphagia induced by 2-deoxy-D-glucose in the presence of the delta-opioid antagonist ICI 174,864.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Attenuation of sham feeding by naloxone is stereospecific: evidence for opioid mediation of orosensory reward

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Beta-funaltrexamine (beta-FNA) decreases deprivation and opioid-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Nor-binaltorphimine decreases deprivation and opioid-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Opioids and consummatory behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Naloxone reduction of stress-related feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Central and peripheral contributions of endogenous opioid systems to nutrient selection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Ventral tegmental injections of morphine but not U-50,488H enhance feeding in food-deprived rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Ventral tegmental injections of a selective μ or δ opioid enhance feeding in food-deprived rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

The role of multiple opioid receptors in the maintenance of stimulation-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Naloxone modifies sugar-water intake in rats drinking with open gastric fistulas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

On the specificity of naloxone as an opiate antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 2. 2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Receptor subtypes in opioid and stimulant reward

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Endophinergic modulation of acceptability of putative reinforcers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Opioid receptors in midbrain dopaminergic regions of the rat. II. Kappa and delta receptor autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Effects of beta-funaltrexamine on ingestive behaviors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Localization of drug reward mechanisms by intracranial injections

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Brain dopamine and reward

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Hypothalamic sites sensitive to morphine and naloxone: effects on feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Electrophysiological studies of neurons in the ventral tegmental area of Tsai

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Multiple opiate receptors: emerging concepts.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

Central mediation of naloxone-induced anorexia in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900539-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(97)00539-8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44347227&oldid=2109620111"